NI
ENTA icon

Numeric Investors’s Enanta Pharmaceuticals ENTA Stock Holding History

Numeric Investors’s Portfolio ENTA Stock Details ENTA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2017
Q4 		$14.6M Buy
248,942
+76,340
+44% +$3.82M 0.11% 190
2017
Q3 		$8.08M Buy
172,602
+96,000
+125% +$3.86M 0.06% 295
2017
Q2 		$2.76M Sell
76,602
-2,598
-3% -$83.1K 0.02% 446
2017
Q1 		$2.44M Sell
79,200
-29,600
-27% -$922K 0.02% 446
2016
Q4 		$3.65M Sell
108,800
-41,100
-27% -$1.18M 0.03% 386
2016
Q3 		$3.99M Buy
149,900
+136,500
+1,019% +$3.17M 0.04% 359
2016
Q2 		$295K Sell
13,400
-74,744
-85% -$1.96M ﹤0.01% 893
2016
Q1 		$2.59M Buy
+88,144
New +$2.45M 0.03% 392
2015
Q4 		– Sell
-32,481
Closed -$1.17M – 1019
2015
Q3 		$1.17M Sell
32,481
-203,100
-86% -$8.72M 0.01% 512
2015
Q2 		$10.6M Buy
+235,581
New +$9.16M 0.12% 158
2015
Q1 		– Sell
-4,000
Closed -$203K – 920
2014
Q4 		$203K Sell
4,000
-107,200
-96% -$4.8M ﹤0.01% 783
2014
Q3 		$4.4M Buy
+111,200
New +$4.43M 0.07% 227
2014
Q2 		– Sell
-12,200
Closed -$488K – 810
2014
Q1 		$488K Sell
12,200
-27,600
-69% -$1M 0.01% 593
2013
Q4 		$1.09M Buy
+39,800
New +$965K 0.02% 456

Other funds holding ENTA

BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
First Manhattan
First Manhattan New York $36.1B AUM 11.5% 1-Year Est. Return
FCM
Farallon Capital Management San Francisco, California $17.5B AUM 50.95% 1-Year Est. Return
KAM
Krensavage Asset Management New York $256M AUM 69.63% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Invesco
Invesco Atlanta, Georgia $1.02T AUM 30.18% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return

Numeric Investors's ENTA Position: Q4 2017 in Review

Numeric Investors increased its Enanta Pharmaceuticals (ENTA) stake by 44% in Q4 2017, buying an estimated $3.82M and bringing the position to 248,942 shares worth $14.6M. The position accounts for 0.11% of the portfolio, ranked #190.

Numeric Investors first reported a position in ENTA in Q4 2013 and has held it in 14 quarters since. 148 funds tracked by Wall St. Rank hold ENTA as of Q4 2017.

  • Numeric Investors held 248,942 shares of Enanta Pharmaceuticals worth $14.6M as of Q4 2017.
  • Numeric Investors bought 76,340 Enanta Pharmaceuticals shares in Q4 2017, an estimated $3.82M.
  • Enanta Pharmaceuticals made up 0.11% of Numeric Investors's portfolio in Q4 2017, its #190 holding.
  • Numeric Investors first reported a position in Enanta Pharmaceuticals in Q4 2013 and has held it in 14 quarters since.
  • 148 funds tracked by Wall St. Rank held Enanta Pharmaceuticals as of Q4 2017.

Based on Numeric Investors's 13F filing for Q4 2017, filed 14 Feb 2018.